Early treatment to prevent progression of SARS-CoV-2 infection

被引：9
作者：
Cohen, Myron S. [1 ]
机构：
[1] Univ N Carolina, Inst Global Hlth & Infect Dis, Bioinformat, Chapel Hill, NC 27517 USA
来源：
LANCET RESPIRATORY MEDICINE | 2022年 / 10卷 / 10期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/S2213-2600(22)00213-2
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：930 / 931
页数：2
相关论文
共 11 条
  • [1] Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
    Bernal, A. Jayk
    da Silva, M. M. Gomes
    Musungaie, D. B.
    Kovalchuk, E.
    Gonzalez, A.
    Delos Reyes, V
    Martin-Quiros, A.
    Caraco, Y.
    Williams-Diaz, A.
    Brown, M. L.
    Du, J.
    Pedley, A.
    Assaid, C.
    Strizki, J.
    Grobler, J. A.
    Shamsuddin, H. H.
    Tipping, R.
    Wan, H.
    Paschke, A.
    Butterton, J. R.
    Johnson, M. G.
    De Anda, C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (06) : 509 - 520
  • [2] Case JB, 2022, bioRxiv, DOI [10.1101/2022.03.17.484787, 10.1101/2022.03.17.484787, DOI 10.1101/2022.03.17.484787]
  • [3] Centers for Disease Control and Prevention, SCI BRIEF EV US UPD
  • [4] Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
    Hammond, Jennifer
    Leister-Tebbe, Heidi
    Gardner, Annie
    Abreu, Paula
    Bao, Weihang
    Wisemandle, Wayne
    Baniecki, MaryLynn
    Hendrick, Victoria M.
    Damle, Bharat
    Simon-Campos, Abraham
    Pypstra, Rienk
    Rusnak, James M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (15) : 1397 - 1408
  • [5] Johns Hopkins University, US
  • [6] ORIGINAL RESEARCH Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020-March 2021
    Kompaniyets, Lyudmyla
    Pennington, Audrey F.
    Goodman, Alyson B.
    Rosenblum, Hannah G.
    Belay, Brook
    Ko, Jean Y.
    Chevinsky, Jennifer R.
    Schieber, Lyna Z.
    Summers, April D.
    Lavery, Amy M.
    Preston, Leigh Ellyn
    Danielson, Melissa L.
    Cui, Zhaohui
    Namulanda, Gonza
    Yusuf, Hussain
    Mac Kenzie, William R.
    Wong, Karen K.
    Baggs, James
    Boehmer, Tegan K.
    Gundlapalli, Adi V.
    [J]. PREVENTING CHRONIC DISEASE, 2021, 18
  • [7] Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19
    Levin, Myron J.
    Ustianowski, Andrew
    De Wit, Stephane
    Launay, Odile
    Avila, Miles
    Templeton, Alison
    Yuan, Yuan
    Seegobin, Seth
    Ellery, Adam
    Levinson, Dennis J.
    Ambery, Philip
    Arends, Rosalinda H.
    Beavon, Rohini
    Dey, Kanika
    Garbes, Pedro
    Kelly, Elizabeth J.
    Koh, Gavin C. K. W.
    Near, Karen A.
    Padilla, Kelly W.
    Psachoulia, Konstantina
    Sharbaugh, Audrey
    Streicher, Katie
    Pangalos, Menelas N.
    Esser, Mark T.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (23) : 2188 - 2200
  • [8] Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
    Montgomery, Hugh
    Hobbs, F. D. Richard
    Padilla, Francisco
    Arbetter, Douglas
    Templeton, Alison
    Seegobin, Seth
    Kim, Kenneth
    Campos, Jesus Abraham Simon
    Arends, Rosalinda H.
    Brodek, Bryan H.
    Brooks, Dennis
    Garbes, Pedro
    Jimenez, Julieta
    Koh, Gavin C. K. W.
    Padilla, Kelly W.
    Streicher, Katie
    Viani, Rolando M.
    Alagappan, Vijay
    Pangalos, Menelas N.
    Esser, Mark T.
    [J]. LANCET RESPIRATORY MEDICINE, 2022, 10 (10) : 985 - 996
  • [9] A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults
    Robbie, Gabriel J.
    Criste, Ryan
    Dall'Acqua, William F.
    Jensen, Kathryn
    Patel, Nita K.
    Losonsky, Genevieve A.
    Griffin, M. Pamela
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 6147 - 6153
  • [10] US Food and Drug Administration, EM US AUTH EUA EVUSH
12